PROTAC® comprised of a highly promiscuous kinase inhibitor conjugated to the cereblon E3 ubiquitin ligase ligand, pomalidomide . Degrades a range of kinases in MOLT-4 and MOLM-14 cell lines. Negative control TL 13-27 is also available. PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.
Huang et al (2018) A chemoproteomic approach to query the degradable kinome using a multi-kinase degrader. Cell Chem.Biol. 25 88 PMID:29129717
















